Lupus for Researchers

Jul 26 2023

NIH-Funded Study Explains Link to Increased Cardiovascular Risks for People with Obstructive Sleep Apnea

July 26, 2023 -- Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing. Obstructive sleep apnea has long been associated...

Read More

From Drugs.com - Clinical Trials • Lupus for Researchers • 0

Jun 01 2023

Study Finds Surgical Treatment of Sleep Apnea More Effective than CPAP Therapy in Preventing the Onset of Type 2 Diabetes

CAMBRIDGE, Mass., June 1, 2023. TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quirónsalud Marbella and Hospital Campo de...

Read More

From Drugs.com - Clinical Trials • Lupus for Researchers • 0

Jun 01 2023

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis

EMERYVILLE, Calif., June 1, 2023 — Kyverna Therapeutics (“Kyverna”), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune diseases, today announced the U.S. Food and Drug...

Read More

From Drugs.com - Clinical Trials • Lupus for Researchers • 0

May 23 2023

Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus

NEW YORK, May 23, 2023. The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of...

Read More

From Drugs.com - Clinical Trials • Lupus for Researchers • 0

Sep 16 2022

DxTerity Receives New York Authorization for Type 1 Interferon Gene Signature Testing for Systemic Lupus Erythematosus Patients

LOS ANGELES, Sept. 16, 2022. The DxTerity IFN-1 gene signature test is for patients with Systemic Lupus Erythematosus (SLE or lupus), a chronic autoimmune disease affecting up to 1 million patients in the US. IFN-1 gene signature testing represents...

Read More

From Drugs.com - Clinical Trials • Lupus for Researchers • 0